The global sleep disorder treatment market, valued at US$ 10143.15 million in 2023, is anticipated to grow at a robust compound annual growth rate (CAGR) of 8.91% during the forecast period from 2024 to 2031, reaching US$ 20077.76 million by the end of 2031.
Sleep disorders, encompassing conditions such as insomnia, sleep apnea, narcolepsy, and restless legs syndrome, affect a significant...